Global Syphilis Testing Market - 2024-2031

Global Syphilis Testing Market - 2024-2031

Global Syphilis Testing market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031

Syphilis is a highly contagious sexually transmitted disease primarily spread through sexual activity (oral or anal sex). It is caused by the bacteria Treponema pallidum. It is asymptomatic most of the time and shows symptoms after several stages. It is still endemic as it exists in developing regions and low-income countries with less healthcare access.

Market Dynamics: Drivers & Restraints

Increasing prevalence of syphilis cases

Syphilis is a preventable sexually transmitted disease, unlike HIV. There is an increase in co-existing cases of HIV and Syphilis as Syphilis is primarily asymptomatic. CDC data show that men who have sex with men are 106 times more likely to be infected with Syphilis than men who have sex with women. The cases of Syphilis are rising in men than in women.

According to the World Health Organization 2023 issue, Syphilis in pregnancy, when not treated, treated late, or treated with the incorrect antibiotic, results in 50−80% of cases with adverse birth outcomes. In 2020, WHO estimated that 7.1 million adults aged 15–49 acquired syphilis globally. In 2022, the UK saw syphilis cases reach their highest level since 1948.

Furthermore, According to The Guardian 2023 issue, syphilis cases soared to almost 8,700 in 2022, the highest since 1948. In 2022, the number of sexual health screenings recovered to 2019 levels, but the figures show that gonorrhea diagnoses up 16% compared with 2019, and syphilis diagnoses up 8%.

False positive test results

The syphilis test kits are not 100% accurate as there are chances for false positive or false negative results. The presence of autoimmune diseases also shows false positive results. According to the Centers for Disease Control and Prevention, nearly 10% of pregnant women with syphilis experience an incorrect positive diagnosis. It can have serious complications, such as anxiety and maternal and fetal health stress.

Segment Analysisn

The global syphilis testing market is segmented based on disease type, technology, test type, end-user and region.

Enzyme immunoassay (EIA) test type is Expected to Dominate Market

Enzyme immunoassay is a type of blood test that tests for syphilis antibodies directed toward the organism. It is a treponemal-specific test used extensively after conventional TPPA or MHA-TP and has been used for many years. Combination kits are launched, which test for syphilis and HIV, as HIV helps detect syphilis as they co-exist in most cases. Hence, dual test kits are found by companies that can detect sexually transmitted diseases.

For instance, in March 2023, BioLytical Laboratories Inc. launched the INSTI Multiplex HIV-1/2 Syphilis Antibody Test for professional use in Canada.

In August 2023, iHealth Labs, Inc. launched the CheckMeSafe home collection Kit for HIV and syphilis testing. This FDA-approved rapid testing kit produces reliable and confidential results in two days.

Geographical Analysis

North America is Expected to Dominate the Global Market

North America is expected to hold the largest region as there is a rising global prevalence of sexually transmitted diseases, including syphilis. The majority has increased after 2020 after the pandemic at alarming rates. Syphilis rates surged, increasing nearly 32% for combined stages of the infection. mong the syphilis data, cases of congenital syphilis rose by an alarming 32%.

According to the New Federal Government Report, the rate of infectious diseases rose to 9% in 2022, and total cases surpassed 207,000 in 2022.

Furthermore, according to BBC, Canada also saw an increase of 389% for infectious syphilis, significantly higher than other STIs, between 2011 and 2019.

Market Segmentation

By Disease Type
• Latent Syphilis
• Late Syphilis
• Congenital Syphilis

By Technology
• Conventional
• Point of Care

By Test Type
• Enzyme immunoassay (EIA)
• Fluorescent treponemal antibody absorption (FTA-ABS)
• Treponema pallidum particle agglutination assay (TPPA)
• Darkfield microscopy
• Micro hemagglutination assay (MHA-TP)

By End User
• Hospitals and Clinics
• Diagnostic Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In August 2023, iHealth Labs, Inc. launched the CheckMeSafe home collection Kit for HIV and syphilis testing. This FDA-approved rapid testing kit produces reliable and confidential results in two days.
• In February 2023, Mylab Discovery Solutions launched new rapid kits for early and rapid detection of sexually transmitted diseases such as HIV, HCV, and syphilis at the point of care.
• In November 2021, MedAccess, the Clinton Health Access Initiative (CHAI), partnered with SD Biosensor to significantly increase access to innovative combined rapid testing for syphilis and HIV.

Competitive Landscape

The major global players in the syphilis testing market include AdvaCare Pharma, Lorne Laboratories Limited, Alpine Biomedicals Pvt Ltd., Thermo Fisher Scientific Inc., Accubiotech Co., Ltd., Vitrosens Biotechnology, Accurex., Cardinal Health., XIAMEN BOSON BIOTECH CO., LTD., Becton, Dickinson, and Company. among others.

Why Purchase the Report?
• To visualize the global syphilis testing market segmentation based on disease type, technology, test type, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of syphilis testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global syphilis testing market report would provide approximately 65 tables, 68 figures, and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies